MA39122B1 - Piperidinyl-tetrahydrochinolines substituted adrenergic antagonists of alpha-2c receptors. - Google Patents
Piperidinyl-tetrahydrochinolines substituted adrenergic antagonists of alpha-2c receptors.Info
- Publication number
- MA39122B1 MA39122B1 MA39122A MA39122A MA39122B1 MA 39122 B1 MA39122 B1 MA 39122B1 MA 39122 A MA39122 A MA 39122A MA 39122 A MA39122 A MA 39122A MA 39122 B1 MA39122 B1 MA 39122B1
- Authority
- MA
- Morocco
- Prior art keywords
- diseases
- diabetic
- tetrahydrochinolines
- micro
- peripheral
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne de nouvelles pipéridinyl-tétrahydrochinolines substituées, leur procédé de production, leur utilisation dans le traitement et/ou la prévention de maladies ainsi que leur utilisation dans la production de médicaments destinés au traitement de maladies, notamment au traitement et/ou à la prévention des maladies suivantes : micro-angiopathies diabétiques, ulcères diabétiques aux extrémités, notamment pour favoriser la cicatrisation d'ulcères du pied diabétiques, insuffisance cardiaque diabétique, maladies cardiaques micro-vasculaires diabétiques, maladies vasculaires périphérique et cardiaque, maladies thromboemboliques et ischémies, troubles de la circulation périphérique, phénomène de raynaud, syndrome crest, troubles de la micro-circulation, claudication intermittente et neuropathies périphérique et autonome.The present invention relates to novel substituted piperidinyl tetrahydrochinolines, to a process for their production, to their use in the treatment and / or prevention of diseases and their use in the production of medicaments for the treatment of diseases, in particular treatment and / or the prevention of the following diseases: diabetic micro-angiopathies, diabetic ulcers at the extremities, in particular to promote the healing of diabetic foot ulcers, diabetic heart failure, diabetic micro-vascular heart diseases, peripheral and cardiac vascular diseases, thromboembolic diseases and ischemia, peripheral circulation disorders, raynaud phenomenon, crest syndrome, micro-circulation disorders, intermittent claudication and peripheral and autonomic neuropathies.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13198385 | 2013-12-19 | ||
| PCT/EP2014/077862 WO2015091414A2 (en) | 2013-12-19 | 2014-12-16 | Substituted piperidinyl-tetrahydroquinolines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA39122A1 MA39122A1 (en) | 2017-11-30 |
| MA39122B1 true MA39122B1 (en) | 2018-04-30 |
Family
ID=49876400
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA39122A MA39122B1 (en) | 2013-12-19 | 2014-12-16 | Piperidinyl-tetrahydrochinolines substituted adrenergic antagonists of alpha-2c receptors. |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR098788A1 (en) |
| MA (1) | MA39122B1 (en) |
-
2014
- 2014-12-16 MA MA39122A patent/MA39122B1/en unknown
- 2014-12-17 AR ARP140104708A patent/AR098788A1/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| AR098788A1 (en) | 2016-06-15 |
| MA39122A1 (en) | 2017-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA35365B1 (en) | Ringed Pyrimidines substituted and their use | |
| CY1120701T1 (en) | SUBSTITUTED PIPERIDINYLO-TETRAHYDROQINOLINES AND THEIR USE AS AN ALPHA-2C ADRENERGIC RECEPTOR COMPETITORS | |
| MA42376B1 (en) | Substituted oxopyridine derivatives | |
| MA34248B1 (en) | SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES AND THEIR USE | |
| MA38349A1 (en) | Estra-1,3,5 (10), 16-tetraeno-3-carboxamide to inhibit 17-beta-hydroxysteroid dehydrogenase (akr1c3) | |
| MA33123B1 (en) | 2-Astmedo-5-aryl-1,2,4-triazolone substitute and its use | |
| MA35844B1 (en) | Pyrimidines and substituted ringed triazines and their use | |
| MA38837B1 (en) | Autotaxin inhibitors containing a heteroaromatic cyclic benzyl amide ring ring | |
| BR112015009948A8 (en) | Activin-actrii antagonists, uses thereof for treating bone diseases and other disorders, and method for monitoring the effectiveness of treating or preventing a bone disease and other disorders | |
| BR112014032699A2 (en) | Pediatric metabolic syndrome treatment methods | |
| MA38060A1 (en) | Amidazo [1,2-a] amino-substituted pyridincarboxamides and their use | |
| WO2015091417A8 (en) | Substituted piperidinyl-tetrahydroquinolines | |
| WO2014186313A8 (en) | Substituted bridged urea analogs as sirtuin modulators | |
| MY182903A (en) | Bicalutamide analogs or (s)-bicalutamide as exocytosis activating compounds for use in the treatment of a lysosomal storage disorder or glycogenosis | |
| BR112016028446A2 (en) | ornithodoros moubata complement inhibitor for use in the treatment of complement-mediated diseases in patients with c5 polymorphism | |
| PH12014501579A1 (en) | Combination of beta-hydroxy-beta-methylbutyrate, arginine and glutamine for use in treating diabetic ulcers | |
| BR112016007238A2 (en) | cyclic thienouracylcarboxamides and their use | |
| BR112015022849A2 (en) | nitroxoline base addition salts and uses thereof | |
| AU2012308243A8 (en) | Use of indolyl and indolinyl hydroxamates for treating heart failure of neuronal injury | |
| MA31902B1 (en) | OXAZOLIDINONES FOR THE TREATMENT AND / OR PROPHYLAXIS OF HEART FAILURE | |
| MA39122A1 (en) | Piperidinyl-tetrahydrochinolines substituted adrenergic antagonists of alpha-2c receptors. | |
| MA39120A1 (en) | Substituted piperidinyl-tetrahydroquinolines antagonists adrenergic alpha-2c receptors. | |
| MA37928A1 (en) | Tri (hetero) arylpyrazoles and their use | |
| CN105521549A (en) | Medicine applying device for treating beriberi | |
| BR112015029579A2 (en) | substituted benzoxazoles |